180 related articles for article (PubMed ID: 19713288)
1. Determinants of decline in glomerular filtration rate in nonproteinuric subjects with or without diabetes and hypertension.
Yokoyama H; Kanno S; Takahashi S; Yamada D; Itoh H; Saito K; Sone H; Haneda M
Clin J Am Soc Nephrol; 2009 Sep; 4(9):1432-40. PubMed ID: 19713288
[TBL] [Abstract][Full Text] [Related]
2. Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function.
Zoppini G; Targher G; Chonchol M; Ortalda V; Negri C; Stoico V; Bonora E
Clin J Am Soc Nephrol; 2012 Mar; 7(3):401-8. PubMed ID: 22282481
[TBL] [Abstract][Full Text] [Related]
3. An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function.
Holtkamp FA; de Zeeuw D; Thomas MC; Cooper ME; de Graeff PA; Hillege HJ; Parving HH; Brenner BM; Shahinfar S; Lambers Heerspink HJ
Kidney Int; 2011 Aug; 80(3):282-7. PubMed ID: 21451458
[TBL] [Abstract][Full Text] [Related]
4. A study of the natural history of diabetic kidney disease (DKD).
Altemtam N; Russell J; El Nahas M
Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177
[TBL] [Abstract][Full Text] [Related]
5. Annual deterioration of renal function in hypertensive patients with and without diabetes.
Polonia J; Azevedo A; Monte M; Silva JA; Bertoquini S
Vasc Health Risk Manag; 2017; 13():231-237. PubMed ID: 28721063
[TBL] [Abstract][Full Text] [Related]
6. Patients with type 2 diabetes having higher glomerular filtration rate showed rapid renal function decline followed by impaired glomerular filtration rate: Japan Diabetes Complications Study.
Moriya T; Tanaka S; Sone H; Ishibashi S; Matsunaga S; Ohashi Y; Akanuma Y; Haneda M; Katayama S
J Diabetes Complications; 2017 Feb; 31(2):473-478. PubMed ID: 27396240
[TBL] [Abstract][Full Text] [Related]
7. Structural Predictors of Loss of Renal Function in American Indians with Type 2 Diabetes.
Fufaa GD; Weil EJ; Lemley KV; Knowler WC; Brosius FC; Yee B; Mauer M; Nelson RG
Clin J Am Soc Nephrol; 2016 Feb; 11(2):254-61. PubMed ID: 26792530
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for progression of renal disease in patient with diabetic nephropathy.
Unsal A; Koc Y; Basturk T; Akgun AO; Sakaci T; Ahbap E
Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):878-83. PubMed ID: 22953635
[TBL] [Abstract][Full Text] [Related]
9. Hyperfiltration, urinary albumin excretion, and ambulatory blood pressure in adolescents with Type 1 diabetes mellitus.
Lovshin JA; Škrtić M; Bjornstad P; Moineddin R; Daneman D; Dunger D; Reich HN; Mahmud F; Scholey J; Cherney DZI; Sochett E
Am J Physiol Renal Physiol; 2018 Apr; 314(4):F667-F674. PubMed ID: 29357443
[TBL] [Abstract][Full Text] [Related]
10. Glomerular filtration rate changes in normoalbuminuric and microalbuminuric Type 2 diabetic patients and normal individuals A 10-year follow-up.
Murussi M; Gross JL; Silveiro SP
J Diabetes Complications; 2006; 20(4):210-5. PubMed ID: 16798471
[TBL] [Abstract][Full Text] [Related]
11. Cystatin C and cystatin glomerular filtration rate as markers of early renal disease in Asian Indian subjects with glucose intolerance (CURES-32).
Surendar J; Anuradha S; Ashley B; Balasubramanyam M; Aravindhan V; Rema M; Mohan V
Metab Syndr Relat Disord; 2009 Oct; 7(5):419-25. PubMed ID: 19419268
[TBL] [Abstract][Full Text] [Related]
12. Long-term prospective observation suggests that glomerular hyperfiltration is associated with rapid decline in renal filtration function: A multiethnic study.
Low S; Zhang X; Wang J; Yeoh LY; Liu YL; Ang KKL; Tang WE; Kwan PY; Tavintharan S; Sum CF; Lim SC
Diab Vasc Dis Res; 2018 Sep; 15(5):417-423. PubMed ID: 29807475
[TBL] [Abstract][Full Text] [Related]
13. Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.
Brocco E; Velussi M; Cernigoi AM; Abaterusso C; Bruseghin M; Carraro A; Sambataro M; Piarulli F; Sfriso A; Nosadini R
J Nephrol; 2001; 14(6):461-71. PubMed ID: 11783602
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome but not obesity measures are risk factors for accelerated age-related glomerular filtration rate decline in the general population.
Stefansson VTN; Schei J; Solbu MD; Jenssen TG; Melsom T; Eriksen BO
Kidney Int; 2018 May; 93(5):1183-1190. PubMed ID: 29395334
[TBL] [Abstract][Full Text] [Related]
15. Risks for glomerular filtration rate decline in association with progression of albuminuria in type 2 diabetes.
Yokoyama H; Kanno S; Takahashi S; Yamada D; Honjo J; Saito K; Sone H; Haneda M
Nephrol Dial Transplant; 2011 Sep; 26(9):2924-30. PubMed ID: 21303964
[TBL] [Abstract][Full Text] [Related]
16. Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes.
Ceriello A; De Cosmo S; Rossi MC; Lucisano G; Genovese S; Pontremoli R; Fioretto P; Giorda C; Pacilli A; Viazzi F; Russo G; Nicolucci A;
Diabetes Obes Metab; 2017 Nov; 19(11):1570-1578. PubMed ID: 28432733
[TBL] [Abstract][Full Text] [Related]
17. Increased Circulating Visfatin Is Associated With Progression of Kidney Disease in Non-Diabetic Hypertensive Patients.
Hsu CY; Huang PH; Chen TH; Chiang CH; Leu HB; Huang CC; Chen JW; Lin SJ
Am J Hypertens; 2016 Apr; 29(4):528-36. PubMed ID: 26298010
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy.
Weldegiorgis M; de Zeeuw D; Li L; Parving HH; Hou FF; Remuzzi G; Greene T; Heerspink HJL
Am J Kidney Dis; 2018 Jan; 71(1):91-101. PubMed ID: 29153995
[TBL] [Abstract][Full Text] [Related]
19. Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical Trial.
Bjornstad P; Nehus E; El Ghormli L; Bacha F; Libman IM; McKay S; Willi SM; Laffel L; Arslanian S; Nadeau KJ;
Am J Kidney Dis; 2018 Jan; 71(1):65-74. PubMed ID: 29157731
[TBL] [Abstract][Full Text] [Related]
20. The impairment of renal function is not associated to altered circulating vascular endothelial growth factor in patients with Type 2 diabetes and hypertension.
Cipriani R; Sensi M; Gabriele A; Gatti A; Mandosi E; Di Mario U; Morano S
Diabetes Nutr Metab; 2004 Apr; 17(2):90-4. PubMed ID: 15244100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
